Q. Why Attend The Biosimilars Commercialisation Summit?
A. It Is The Only Conference With A Dedicated Focus On Planning Your Market Access Strategy and Winning The Race To Market
There is an undoubted advantage to bringing your biosimilar to market first, but how and what do you do when you get there? With huge commercial potential, and vast competition, your market access plan is essential to the success of your biosimilar.
Discover how you can win the race to market by hearing from the leading figures in the global biosimilars industry, in over 20-hours of case-studies detailing peer-proven techniques in maximising patient uptake and ensuring your market access strategy to established and emerging markets.
The inaugural Biosimilars Commercialisation Summit, is the only forum where you will not only dig deep into the challenges surrounding stakeholder confidence, but also objection handling, pricing and avoiding competition in the global market in this booming industry, are you ready to compete in the race?
Benefits of Attendance
Plan your global access strategies with market insights from the EU, US, and Emerging Markets
Assess national policy developments such as education, incentives and government investments
Discuss the sustainability of the biosimilars market and strategise on how to safeguard your future profits
Secure international regulatory approval with advice about global regulatory compliance
Deep-dive into the latest trends and innovations in analytics, development & pharmacovigilance